ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 67.17 USD 1.27% Market Closed
Market Cap: 1.5B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ANIP Price Targets Summary
ANI Pharmaceuticals Inc

Wall Street analysts forecast ANIP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ANIP is 82.62 USD with a low forecast of 62.62 USD and a high forecast of 98.7 USD.

ANIP Lowest Forecast
Wall Street Target
62.62 USD
7% Downside
ANIP Average Forecast
Wall Street Target
82.62 USD
23% Upside
ANIP Highest Forecast
Wall Street Target
98.7 USD
47% Upside
Lowest
Price Target
62.62 USD
7% Downside
Average
Price Target
82.62 USD
23% Upside
Highest
Price Target
98.7 USD
47% Upside
ANI Pharmaceuticals Inc Competitors:
Price Targets
KLBF
Kalbe Farma Tbk PT
55% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
16% Upside
MRK
Merck KGaA
43% Upside
600216
Zhejiang Medicine Co Ltd
35% Upside
KLBF
Kalbe Farma Tbk PT
55% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
16% Upside
MRK
Merck KGaA
43% Upside
600216
Zhejiang Medicine Co Ltd
35% Upside
R
RHONEMA
Rhone Ma Holdings Bhd
11% Upside
S
2005
SSY Group Ltd
69% Upside
LQDA
Liquidia Corp
74% Upside
A
AHEALTH
Apex Healthcare Bhd
31% Upside

Revenue
Forecast

Revenue Estimate
ANI Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 22%. The projected CAGR for the next 3 years is 12%.

22%
Past Growth
12%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ANI Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's operating income is -24%. The projected CAGR for the next 3 years is 352%.

-24%
Past Growth
352%
Estimated Growth
Estimates Accuracy
-66%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ANI Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
What are analyst estimates?

See Also

Summary
ANIP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANIP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANIP stock valuation using valuation multiples.
Wall Street Estimates
ANIP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANIP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ANIP's stock price target?
Price Target
82.62 USD

According to Wall Street analysts, the average 1-year price target for ANIP is 82.62 USD with a low forecast of 62.62 USD and a high forecast of 98.7 USD.

What is ANI Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's revenue is 22%. The projected CAGR for the next 3 years is 12%.

What is ANI Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
352%

For the last 8 years the compound annual growth rate for ANI Pharmaceuticals Inc's operating income is -24%. The projected CAGR for the next 3 years is 352%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.